StockData
BioNTech SE logo

BioNTech SE (BNTX) income statement

BNTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 10, 2026Score 3/30
$80.96−0.42 (-0.52%)

Close on Nov 20, 2026Market cap $20.34BP/E –Yield –

See a number that looks wrong?